相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IL-2 antibodies in type 1 diabetes and during IL-2 therapy
Guillaume Churlaud et al.
DIABETOLOGIA (2018)
Pharmacodynamics of regulatory T cells in mice and humans treated with low-dose IL-2
Guillaume Churlaud et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses
Fabien Pitoiset et al.
CYTOMETRY PART A (2018)
CD4+T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2
Denis Comte et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Caroline von Spee-Mayer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
Jing He et al.
NATURE MEDICINE (2016)
Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes
Aixin Yu et al.
DIABETES (2015)
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Michelle Rosenzwajg et al.
JOURNAL OF AUTOIMMUNITY (2015)
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases
Yun R. Li et al.
NATURE MEDICINE (2015)
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
David Klatzmann et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy
Frederic Van Gool et al.
BLOOD (2014)
Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
Alana A. Kennedy-Nasser et al.
CLINICAL CANCER RESEARCH (2014)
Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
Sawa Ito et al.
MOLECULAR THERAPY (2014)
Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
Emeline Castela et al.
JAMA DERMATOLOGY (2014)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken-ichi Matsuoka et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell Differentiation
Andre Ballesteros-Tato et al.
IMMUNITY (2012)
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
David Saadoun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity
Linda A. Lieberman et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
Kajsa Wing et al.
NATURE IMMUNOLOGY (2010)
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Arian Laurence et al.
IMMUNITY (2007)
分享论文
